sever
neurolog
complic
season
influenza
includ
influenzaassoci
encephalopathyenceph
iae
caus
consider
morbid
mortal
healthi
children
preexist
neurolog
diseas
recent
estim
indic
annual
incid
iae
australia
per
children
year
around
hospit
influenza
case
associ
iae
popul
show
similar
higher
incid
japan
annual
incid
iae
record
neurolog
complic
attribut
influenza
rang
mildli
alter
mental
state
vertigo
brief
febril
seizur
life
threaten
complic
statu
epilepticu
mening
stroke
demyelin
diseas
antivir
agent
predominantli
neuraminidas
inhibitor
immunomodulatori
treatment
corticosteroid
intraven
immunoglobulin
use
treat
patient
influenzaassoci
neurolog
diseas
limit
evid
efficaci
thought
extens
chang
mri
correl
diseas
sever
avail
biomark
predict
outcom
australian
influenza
season
typic
occur
juli
octob
season
saw
highest
level
influenza
report
sinc
pandem
year
author
report
note
appar
increas
iae
sever
neurolog
complic
describ
clinic
present
laboratori
test
neuroimag
treatment
shortterm
outcom
case
addit
observ
elev
cerebrospin
fluid
csf
neopterin
e
marker
central
nervou
system
cn
inflamm
e
amongst
children
iae
previous
describ
compar
frequenc
iae
influenza
season
previous
publish
incid
estim
materi
method
identifi
children
age
year
evid
influenza
associ
sever
neurolog
diseas
includ
statu
epilepticu
moder
sever
encephalopathi
admit
two
paediatr
hospit
compris
sydney
children
hospit
network
largest
paediatr
network
australia
case
ascertain
april
octob
children
hospit
westmead
case
identifi
recruit
preexist
surveil
studi
australian
childhood
enceph
studi
ace
influenza
complic
network
flucan
surveil
studi
sydney
children
hospit
children
identifi
neurolog
consult
databas
children
includ
requir
hospit
admiss
consult
paediatr
neurologist
neurolog
complic
worsen
preexist
neurolog
condit
due
proven
influenza
children
includ
either
present
statu
epilepticu
min
longer
reach
level
diagnost
certainti
brighton
encephalopathi
score
children
exclud
influenza
confirm
neurolog
symptom
mild
hospit
admiss
requir
altern
diagnosi
could
better
explain
present
data
retrospect
collect
electron
medic
record
collect
demograph
data
present
clinic
characterist
intens
care
unit
icu
admiss
length
stay
laboratori
result
includ
csf
test
influenza
test
csf
analysi
includ
cell
count
protein
glucos
microscopi
lactat
oligoclon
band
neopterin
influenza
pcr
elev
csf
neopterin
result
defin
nmoll
electroencephalogram
report
brain
magnet
reson
imag
mri
weight
flair
diffus
weight
imag
assess
neurologist
sp
neuroradiologist
cch
neuroradiologist
blind
diagnosi
review
mri
influenza
commonli
acut
diagnos
detect
influenza
rna
respiratori
sampl
hospit
use
multiplex
pcr
assay
seegen
south
korea
detect
respiratori
virus
assay
target
influenza
b
perform
daili
turnaround
time
day
sydney
children
hospit
assay
also
target
subtyp
influenza
strain
pandem
strain
influenza
serolog
request
diagnos
recent
influenza
ill
perform
use
complement
fixat
assay
virion
germani
treatment
given
includ
oseltamivir
empir
aciclovir
gener
cephalosporin
ivig
corticosteroid
e
u
r
p
e
n
j
u
r
n
l
f
p
e
r
c
n
e
u
r
l
g
plasmapheresi
record
time
admiss
commenc
oseltamivir
record
case
assign
modifi
rankin
scale
mr
base
examin
present
discharg
hospit
mr
rang
symptom
death
poor
outcom
mr
score
indic
least
moder
disabl
requir
assist
relat
categor
variabl
investig
use
two
tail
fisher
exact
test
mannewhitney
u
test
use
determin
relat
continu
variabl
ethic
approv
grant
sydney
children
hospit
network
ethic
committe
twenti
two
children
includ
case
seri
femal
median
age
present
five
year
rang
year
eight
children
preexist
epilepsi
andor
development
delay
one
child
immunodefici
hypogammaglobulinemia
receiv
monthli
ivig
child
present
statu
epilepticu
child
record
receiv
season
influenza
vaccin
eleven
children
met
level
brighton
criteria
enceph
design
influenza
associ
encephalopathyenceph
iae
two
children
iae
previou
episod
acut
dissemin
encephalomyel
adem
complet
clinic
radiolog
recoveri
tabl
case
one
child
mosaic
tetrasomi
x
anoth
epilepsi
development
delay
remain
children
seri
statu
epilepticu
contrast
children
iae
half
group
n
preexist
neurolog
diseas
includ
two
children
refractori
genet
epilepsi
dravet
syndrom
major
children
fever
twothird
respiratori
symptom
half
present
neurolog
symptom
within
two
day
onset
influenza
ill
sixteen
children
present
alter
level
conscious
seizur
occur
children
stage
ill
statu
epilepticu
frequent
n
neurolog
find
present
weak
n
pyramid
sign
n
movement
disord
n
ataxia
n
hallucin
mening
cranial
neuropathi
pupillari
chang
infrequ
major
children
n
influenza
subtyp
n
half
half
four
children
respiratori
pathogen
coidentifi
npa
rhinoviru
coronaviru
mycoplasma
pneumonia
enteroviru
detect
npa
one
child
absent
csf
one
blood
cultur
posit
staphylococcu
epidermidi
assess
contamin
lumbar
punctur
perform
children
consid
clinic
indic
tabl
lumbar
punctur
perform
children
present
statu
epilepticu
alon
usual
known
preexist
epilepsi
one
case
acut
necrotis
encephalopathi
ane
deem
unwel
undergo
second
lumbar
punctur
measur
neopterin
sampl
csf
show
pleocytosi
elev
protein
third
n
influenza
pcr
csf
posit
children
test
immunocompet
previous
well
year
old
csf
neopterin
elev
children
test
seven
children
consider
elev
rang
nmoll
normal
nmoll
one
borderlin
result
nmoll
csf
neopterin
measur
one
child
present
statu
epilepticu
nmoll
borderlin
result
children
iae
rais
csf
neopterin
three
csf
pleocytosi
cellsmm
two
elev
csf
protein
gl
gl
oligoclon
band
measur
serum
andor
csf
children
iae
present
children
iae
antineuron
antibodi
test
perform
serum
andor
csf
usual
nmda
vgkc
tabl
neg
apart
two
case
mildli
elev
antithyroid
antibodi
routin
laboratori
data
normal
mildli
abnorm
children
tabl
mri
brain
perform
children
show
new
abnorm
eight
iae
common
acut
mri
abnorm
presenc
hyperintens
diffus
restrict
n
gadolinium
enhanc
n
spectrum
radiolog
featur
shown
fig
divers
clinicoradiolog
syndrom
diagnos
includ
ane
n
acut
encephalopathi
biphas
seizur
aesd
n
posterior
revers
encephalopathi
pre
n
hemiconvuls
hemiplegia
syndrom
hh
n
cerebel
genet
test
ranbind
protein
perform
child
ane
tabl
case
child
die
anelik
ill
tabl
case
neg
one
child
met
criteria
iae
subsequ
found
mutat
polymeras
gamma
polg
gene
tabl
case
fourteen
children
admit
icu
nine
requir
mechan
ventil
thirteen
children
receiv
oseltamivir
median
time
commenc
oseltamivir
present
day
mean
day
iqr
day
day
five
case
two
icu
ventil
children
commenc
oseltamivir
nine
day
admiss
contrast
nineteen
children
treat
gener
cephalosporin
receiv
aciclovir
nineteen
receiv
anticonvuls
continu
discharg
firstlin
e
u
r
p
e
n
j
u
r
n
l
f
p
e
r
c
n
e
u
r
l
g
immunomodulatori
treatment
corticosteroid
andor
ivig
plasmapheresi
given
nine
children
iae
corticosteroid
n
ivig
n
plasmapheresi
n
none
statu
epilepticu
alon
median
length
icu
hospit
stay
four
day
rang
day
rang
day
respect
children
iae
like
longer
hospit
mean
day
vs
day
p
picu
admiss
mean
day
vs
day
p
compar
children
statu
epilepticu
one
child
iae
die
follow
anelik
ill
although
mri
find
atyp
tabl
case
postmortem
inconclus
show
generalis
cerebr
oedema
featur
acut
hemorrhag
leucoenceph
ten
children
iae
mr
score
normal
baselin
discharg
hospit
children
iae
higher
mr
score
mr
moder
disabl
compar
statu
epilepticu
chang
mean
mr
signific
two
group
children
iae
chang
mr
point
statu
epilepticu
group
mean
increas
mr
point
pvalu
nearli
children
mri
diffus
restrict
poor
outcom
child
mri
diffus
restrict
good
outcom
posterior
revers
encephalopathi
syndrom
pre
among
children
iae
consider
elev
neopterin
four
mr
three
mild
deficit
mr
mean
increas
mr
point
seven
children
highli
elev
csf
neopterin
nmoll
case
seri
observ
two
group
children
present
sever
influenza
relat
neurolog
diseas
one
group
children
fulfil
criteria
iae
group
often
preexist
neurolog
diseas
present
statu
epilepticu
otherwis
fulfil
criteria
iae
amongst
case
iae
elev
csf
neopterin
appear
correl
presenc
diffus
restrict
mri
brain
advers
outcom
use
oseltamivir
infrequ
among
case
although
use
antibiot
occur
major
one
child
document
influenza
vaccin
even
amongst
preexist
neurolog
comorbid
despit
fact
recommend
australia
influenza
associ
neurolog
complic
thought
occur
due
inflammatori
immunemedi
respons
influenza
infect
rather
direct
viral
invas
among
iae
observ
similar
previou
author
csf
pleocytosi
detect
influenza
csf
occur
minor
n
n
howev
csf
neopterin
biomark
inflamm
elev
children
iae
n
neopterin
catabol
product
guanosin
triphosph
gtp
synthes
human
macrophag
upon
stimul
interferon
gamma
measur
urin
serum
csf
serum
neopterin
level
use
diagnosi
monitor
system
infecti
inflammatori
diseas
hiv
csf
neopterin
reflect
intrathec
product
microgli
cell
accur
detect
cn
inflammatori
diseas
infecti
immun
mediat
recent
review
assess
biomark
csf
inflamm
found
among
clinic
avail
test
csf
neopterin
perform
better
presenc
oligoclon
band
csf
pleocytosi
detect
cn
inflamm
limit
data
regard
prognost
signific
biomark
iae
proinflammatori
cytokin
may
impair
blood
brain
barrier
induc
apoptosi
neuron
elev
cytokin
tumour
necrosi
factor
alpha
demonstr
children
iae
correl
poorer
outcom
test
csf
outsid
research
set
current
unavail
clasmatodendrosi
abnorm
morpholog
chang
astrocyt
occur
presum
due
effect
proinflammatori
cytokin
recent
suggest
patholog
featur
iae
autopsi
clasmatodendrosi
found
cerebr
white
matter
thalamu
corpu
callosum
cerebellum
thalamu
hippocampu
children
iae
may
correl
mri
chang
commonli
seen
previou
author
associ
abnorm
mri
brain
poorer
outcom
cohort
mri
brain
abnorm
divers
common
particularli
diffus
restrict
subcort
white
matter
diffus
restrict
correl
poor
outcom
apart
child
pre
associ
elev
csf
neopterin
case
studi
iae
requir
evalu
whether
signific
elev
csf
neopterin
particularli
combin
diffus
restrict
mri
chang
could
predict
short
longterm
outcom
oseltamivir
neuramidas
inhibitor
prevent
releas
influenza
viru
infect
cell
shown
reduc
influenza
symptom
otherwis
healthi
children
h
ci
h
p
children
treat
oseltamivir
signific
delay
commenc
case
day
hospit
contrast
empir
gener
cephalosporin
aciclovir
use
frequent
may
relat
percept
among
practition
antiinfluenza
therapi
littl
benefit
suggest
accord
local
guidelin
children
enceph
empir
treat
oseltamivir
influenza
season
may
octob
evid
use
immunotherapi
ivig
corticosteroid
iae
limit
howev
case
seri
children
iae
treat
firstlin
immunotherapi
uncertain
benefit
seriou
side
effect
report
burden
influenza
australia
particularli
eastern
state
highest
seen
sinc
pandem
base
iae
incid
estim
publish
britton
et
al
influenza
season
australia
popul
coverag
hospit
calcul
would
expect
case
iae
children
year
per
year
iae
case
frequenc
observ
cohort
twice
expect
point
estim
base
previou
incid
estim
within
confid
interv
contribut
valid
estim
britton
et
al
shortterm
outcom
cohort
particularli
iae
alarm
poor
outcom
signific
rate
icu
admiss
among
group
children
statu
epilepticu
high
children
iae
often
nonia
children
experi
signific
chang
mr
support
previou
observ
survivor
iae
pandem
recent
nonpandem
influenza
season
australia
experienc
signific
ongo
disabl
previous
shown
larg
retrospect
enceph
cohort
studi
icu
admiss
mri
diffus
restrict
statu
epilepticu
risk
factor
longterm
abnorm
outcom
risk
factor
common
children
iae
cohort
medium
longterm
outcom
cohort
assess
includ
formal
neuropsycholog
test
research
requir
understand
modul
cn
inflammatori
cascad
present
iae
order
modul
long
term
neurodis
overal
influenza
immunis
rate
australia
low
howev
recent
observ
rate
vaccin
receipt
among
children
even
lower
four
agespecif
quadrival
influenza
vaccin
contain
two
strain
influenza
michigan
hong
kong
two
strain
influenza
b
brisban
phuket
avail
children
older
six
month
elig
vaccin
vaccin
provid
free
children
neurolog
diseas
cohort
one
child
document
influenza
vaccin
although
third
children
elig
free
immunis
remaind
could
receiv
immunis
cost
around
aud
emphasis
sever
syndrom
advers
outcom
observ
consid
prevent
follow
high
rate
influenza
relat
morbid
includ
case
new
south
wale
australian
state
introduc
univers
fund
season
influenza
immunis
children
age
month
year
seri
limit
describ
children
sever
influenzaassoci
neurolog
complic
includ
children
mild
neurolog
complic
children
preexist
epilepsi
may
alway
test
influenza
may
underrepres
collect
clinic
data
retrospect
electron
data
incomplet
season
influenza
immunis
statu
alway
clearli
record
although
review
australian
immunis
regist
verifi
vaccin
statu
possibl
influenza
subtyp
npa
sampl
csf
influenza
pcr
test
routin
perform
se
group
csf
studi
includ
csf
neopterin
perform
infrequ
mri
brain
infrequ
request
due
unabl
use
group
direct
control
find
elev
csf
neopterin
iae
group
serial
csf
neopterin
assess
treatment
clinic
progress
perform
first
seri
demonstr
elev
csf
neopterin
marker
cn
inflamm
occur
commonli
children
iae
csf
neopterin
may
use
diagnost
marker
iae
role
prognost
marker
e
u
r
p
e
n
j
u
r
n
l
f
p
e
r
c
n
e
u
r
l
g
requir
evalu
mri
diffus
restrict
associ
poor
outcom
iae
shortterm
outcom
children
neurolog
complic
influenza
especi
within
iae
group
alarm
nearli
twothird
children
poor
outcom
despit
receipt
icu
support
anticonvuls
firstlin
immunotherapi
antivir
treatment
given
sever
influenza
associ
neurolog
complic
recommend
treat
test
approach
use
oseltamivir
children
present
acut
encephalopathyenceph
influenza
season
final
season
influenza
vaccin
univers
provid
children
risk
sever
influenza
better
educ
awar
increas
uptak
paediatr
popul
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
